News about Engineering

CSIR-CDRI signs agreement with Marc Labs to develop drug for heart attack and stroke

The agreement has been signed for the development of a synthetic compound S-007-867 as modulator of blood coagulation cascade, in particular as inhibitor of collagen induced platelet aggregation. This may be helpful in treating patient population of coronary and cerebral artery diseases

Engineering | 12/06/2021 | By Darshana |  381

CSIR-IICT, Lee Pharma sign agreement to produce 2-D

Lee Pharma has entered into a non-exclusive licensing agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-Deoxy-D-Glucose (2-DG) recently developed by DRDO and Dr Reddy's Laboratories to treat COVID patients, informed a statement

Engineering | 11/06/2021 | By Darshana |  218

CMO Selkirk blueprints $90M factory to help bring injectable drug manufacturing stateside

Even as the pandemic winds down in the U.S., the push to bring drug manufacturing stateside persists. Privately held contract manufacturer Selkirk Pharma is teeing up a flagship facility in Washington state to do just that

Engineering | 10/06/2021 | By Darshana |  274

Zydus Cadila receives US FDA approval for fluphenazine HCl tablets

Zydus Cadila has received final approval from US FDA to market fluphenazine hydrochloride tablets in the strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg (Prolixin tablets). This medication is used to treat symptoms of a certain type of mental/mood condition (schizophrenia)

Engineering | 31/05/2021 | By Darshana |  210

Bharat Biotech signs MoU with GCVC for drug substance for Covaxin

Bharat Biotech International Limited has signed an MoU with Gujarat Covid Vaccine Consortium (GCVC) towards contract manufacturing for the drug substance for Covaxin

Engineering | 28/05/2021 | By Darshana |  187

Moderna's phase 2/3 TeenCOVE study of Covid-19 vaccine, mRNA-1273 in adolescents meets primary endpoint

Moderna announced that the phase 2/3 study of its Covid-19 vaccine (mRNA-1273) in adolescents has met its primary immunogenicity endpoint, successfully bridging immune responses to the adult vaccination. In the study, no cases of Covid-19 were observed in participants

Engineering | 27/05/2021 | By Darshana |  193

Zydus Cadila launches Ujvira for breast cancer treatment

Zydus Cadila, a global innovation driven healthcare company, launched trastuzumab emtansine, the first antibody drug conjugate (ADC) biosimilar and a highly effective drug for treating both early and advanced HER2 positive breast cancer, under the brand name 'Ujvira'. HER2 positive breast cancer is considered an aggressive form and constitutes 20 to 25%

Engineering | 25/05/2021 | By Darshana |  633

Ambu to launch US FDA approved sterile, single-use duodenoscope, aScope Duodeno

The Ambu, a company develop, produce and market diagnostic and life-supporting devices for hospitals and rescue services, announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for aScope Duodeno on 17 July 2020 and is now ready for commercial launch as planned

Engineering | 20/07/2020 | By Darshana |  607

Wipro 3D collaborates with SCTIMST launches emergency breathing assist system, AirBridge

Wipro 3D, a business of Wipro Infrastructure Engineering, in technical collaboration with Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Thrivuvananthapuram, has launched AirBridge, the Wipro Chitra Emergency Breathing Assist System (EBAS)

Engineering | 08/07/2020 | By Darshana |  433

FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer

Today, the U.S. Food and Drug Administration approved Keytruda (pembrolizumab) for intravenous injection for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer

Engineering | 01/07/2020 | By Darshana |  404